Harbin Gloria Pharmaceuticals (002437) — Capital Reinvestment Ratio
Latest as of September 2025:
0.02x
Harbin Gloria Pharmaceuticals (002437) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥182.89 Million) in capital expenditures (CN¥4.26 Million). See cash generation quality of Harbin Gloria Pharmaceuticals to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥182.89 Million
CNY
Capital Expenditures
CN¥4.26 Million
CNY
Data as of
Sep 2025
Most recent filing
Harbin Gloria Pharmaceuticals Capital Reinvestment Ratio (2007–2025)
This chart tracks Harbin Gloria Pharmaceuticals's Capital Reinvestment Ratio across 19 annual periods.
Annual Capital Reinvestment Ratio for Harbin Gloria Pharmaceuticals (2007–2025)
Year-by-year Capital Reinvestment Ratio for Harbin Gloria Pharmaceuticals from 2007 to 2025. For live market cap and broader valuation context, see 002437 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥273.36 Million | CN¥23.81 Million | ▼ -43.1% |
| 2024 | 0.15x | CN¥410.94 Million | CN¥62.90 Million | ▲ +41.7% |
| 2023 | 0.11x | CN¥274.18 Million | CN¥29.62 Million | ▼ -14.4% |
| 2022 | 0.13x | CN¥261.62 Million | CN¥33.01 Million | ▲ +0.3% |
| 2021 | 0.13x | CN¥274.18 Million | CN¥34.51 Million | ▼ -96.3% |
| 2020 | 3.42x | CN¥12.76 Million | CN¥43.66 Million | ▲ +4211.5% |
| 2019 | 0.08x | CN¥610.37 Million | CN¥48.43 Million | ▼ -11.6% |
| 2018 | 0.09x | CN¥1.16 Billion | CN¥104.34 Million | ▼ -69.9% |
| 2017 | 0.30x | CN¥651.80 Million | CN¥194.63 Million | ▲ +67.6% |
| 2016 | 0.18x | CN¥1.04 Billion | CN¥185.34 Million | ▼ -55.8% |
| 2015 | 0.40x | CN¥702.05 Million | CN¥283.10 Million | ▲ +115.9% |
| 2014 | 0.19x | CN¥674.04 Million | CN¥125.89 Million | ▼ -48.2% |
| 2013 | 0.36x | CN¥453.02 Million | CN¥163.35 Million | ▼ -48.6% |
| 2012 | 0.70x | CN¥205.89 Million | CN¥144.37 Million | ▼ -46.0% |
| 2011 | 1.30x | CN¥128.61 Million | CN¥166.90 Million | ▼ -39.3% |
| 2010 | 2.14x | CN¥112.59 Million | CN¥240.88 Million | ▲ +494.5% |
| 2009 | 0.36x | CN¥170.82 Million | CN¥61.47 Million | ▼ -45.4% |
| 2008 | 0.66x | CN¥57.81 Million | CN¥38.08 Million | ▲ +161.3% |
| 2007 | 0.25x | CN¥52.26 Million | CN¥13.17 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow